Northern Clinical Research Centre

Clinical Drug Trials

The NCRC is able to provide support for clinical drug trials conducted at Northern Health by providing resources and staff who have experience in ethics applications and the coordination of clinical drug trials.

Resources

Standard Operating Procedures

• Research Ethics Submissions
• Recruiting and Consenting Research Participants
• Trial Monitoring and Reporting
• Serious Adverse Event Reporting
• Project Management

Education

• Clinical Research Drug Trials Study Day - 22 September 2010

Current Clinical Drug Trials

Insulin Resistance Intervention after Stroke (IRIS) trial is funded by the National Institute of Neurological Disorders and Stroke to determine the effectiveness of pioglitazone, an agent that reduces insulin resistance and has other potent vasoprotective effects, in lowering the risk for stroke or myocardial infarction among non-diabetic men and women with a recent ischemic stroke or TIA and insulin resistance. IRIS is a randomized, double-blind, placebo controlled trial that will enroll 3136 subjects at 100 hospitals.

Useful Links

• Medicines Australia - Examples of agreements, brochures and patient information
• Australian Government Therapeutic Goods Administration - General information about clinical trials in Australia
• Australia & New Zealand Clinical Trials Registry
• Northern Health Ethics Committee
• Victorian Managed Insurance Authority (VMIA)- Research Governance Toolkit, Clinical trial guidelines, Standard Operating Procedures, Agreements, etc.
• National Health & Medical Research Council

 Other clinical trials being conducted at Northern Health include:

• Oncology
• Cardiology
• Intensive Care Unit